Tag:
Kathleen Sebelius
Latest Headlines
Latest Headlines
FDA battling White House over politicization of regulation
Politics has peppered Obama loyalists' spats with FDA officials over regulatory issues, according to a New York Times report.
Leukemia drug shortage averted for now, FDA says
Disaster averted, say federal health officials. HHS Secretary Kathleen Sebelius told Congress yesterday that new supplies of the critically scarce drug methotrexate would be released in the coming
Novartis, HHS unveil pandemic-ready vax plant
A joint effort by government and industry has begotten a nearly $1 billion cell-culture flu vaccine manufacturing facility. Novartis ( $NVS ) and the U.S. Department of Health and Human Services
Harvard Prof: FDA should be independent after Plan B debacle
HHS Secretary Kathleen Sebelius ' controversial decision to overrule the FDA on access to the Plan B female contraceptive has prompted a new call for the FDA to become an independent agency--taking
FDA rejects citizen's petition on Plan B
After a week of arguments and protests, the FDA has denied a citizen's petition from the Center for Reproductive Rights on allowing greater access to generic versions of the Plan B contraceptive for
HHS chief smacks down FDA's Plan B decision
Look for more hot debate about HHS Secretary Kathleen Sebelius' decision to trump the FDA on expanding access to the Plan B contraceptive. People are talking not only because it's about birth
HHS isn't exercising some Medicare drug powers
Medicare could cut its prescription drug spending by several millions of dollars annually if HHS Secretary Kathleen Sebelius exercised her existing authority, according to the agency's inspector
HHS takes both sides of egg bet for vax-making
The U.S. Department of Health and Human Services has re-upped in the egg business at the same time it's working to get out. Under the Biomedical Advanced Research and Development Authority, the
HHS chief promises cell-based flu vax in 2011
HHS Secretary Kathleen Sebelius says that the agency's $487 million contract with Novartis is helping spur development of a new cell-based flu vaccine that is scheduled to be on the market in time
Sebelius report re-states need for vax-making makeover
Expect HHS to complete a draft solicitation for vaccine manufacturing and development "centers of innovation" in the coming weeks. Secretary Kathleen Sebelius, staying on message since the beginning
